Tower Bridge Advisors’s AstraZeneca AZN Stock Holding History

Tower Bridge Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,932	Closed	-$268K	–	197
2023 Q1	$268K	Buy	1,932 +332	+21%	+$44.7K	0.02%	210
2022 Q4	$217K	Buy	+1,600	New	+$201K	0.02%	228
2022 Q3	–	Sell	-1,600	Closed	-$211K	–	236
2022 Q2	$211K	Sell	1,600 -2,899	-64%	-$380K	0.02%	232
2022 Q1	$597K	Hold	4,499	–	–	0.04%	185
2021 Q4	$524K	Sell	4,499 -212	-5%	-$24.9K	0.03%	194
2021 Q3	$566K	Buy	+4,711	New	+$548K	0.04%	190

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tower Bridge Advisors's AZN Position: Q2 2023 in Review

Tower Bridge Advisors sold out of AstraZeneca (AZN) in Q2 2023, closing a stake of 1,932 shares — an estimated $268K sold.

Tower Bridge Advisors first reported a position in AZN in Q3 2021 and held it in 6 quarters. The position peaked at $597K in Q1 2022. 1,090 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Tower Bridge Advisors reported no remaining AstraZeneca position as of Q2 2023 after selling out during the quarter.
Tower Bridge Advisors sold 1,932 AstraZeneca shares in Q2 2023, an estimated $268K.
Tower Bridge Advisors first reported a position in AstraZeneca in Q3 2021 and held it in 6 quarters.
Tower Bridge Advisors's AstraZeneca position peaked at $597K in Q1 2022.
1,090 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Tower Bridge Advisors's 13F filing for Q2 2023, filed 20 Jul 2023.